Patents by Inventor Jennie P. Mather

Jennie P. Mather has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • B7-H3L cell surface antigen and antibodies that bind thereto
    Patent number: 9574007
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: February 21, 2017
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
    Publication number: 20140328857
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Application
    Filed: June 3, 2014
    Publication date: November 6, 2014
    Applicant: MACROGENICS WEST, INC.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • B7-H3L cell surface antigen and antibodies that bind thereto
    Patent number: 8779098
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, RAAG10. The invention also provides a family of monoclonal antibodies that bind to antigen RAAG10, methods of diagnosing and treating various human cancers and diseases that express RAAG10.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: July 15, 2014
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Ronghao Li, Zhuangyu Pan, Penelope E. Roberts
  • ADAM-9 modulators
    Patent number: 8361475
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, KID24. The invention also provides modulators of KID24, including a family of monoclonal antibodies that bind to antigen KID24, and methods of diagnosing and treating various human cancers and diseases with KID24.
    Type: Grant
    Filed: January 14, 2010
    Date of Patent: January 29, 2013
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Deryk T. Loo
  • KID31 and antibodies that bind thereto
    Patent number: 8313916
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, KID31. The invention also provides modulators of KID31, including a family of monoclonal antibodies that bind to antigen KID31, and methods of diagnosing and treating various human cancers and diseases with KID31.
    Type: Grant
    Filed: February 13, 2010
    Date of Patent: November 20, 2012
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Deryk T. Loo
  • Human cancer stem cells
    Patent number: 8309354
    Abstract: This invention discloses isolated populations of human cancer stem cells. Methods for characterizing, isolating and culturing human cancer stem cells are also disclosed. Uses for human cancer stem cells are provided.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: November 13, 2012
    Assignee: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts
  • TES7 and antibodies that bind thereto
    Patent number: 8216570
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, TES7. The invention also provides a family of monoclonal antibodies that bind to antigen TES7, methods of diagnosing and treating various human cancers and diseases with TES7.
    Type: Grant
    Filed: March 16, 2010
    Date of Patent: July 10, 2012
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Tony W. Liang
  • Antibodies to oncostatin M receptor
    Patent number: 8216578
    Abstract: The invention provides characterization of the disease and cancer-associated antigen, OSM-R.beta. The invention also provides modulators of OSM-R.beta, including a family of monoclonal antibodies that bind to antigen OSM-R.beta, and methods of diagnosing and treating various human cancers and diseases associated with OSM-R.beta.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: July 10, 2012
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts
  • Transferrin receptor antibodies
    Patent number: 8187594
    Abstract: The invention provides further characterization of the disease and cancer-associated antigen, transferrin receptor. The invention also provides a novel family of antibodies that bind to the transferrin receptor, methods of diagnosing and treating various human cancers and diseases that express transferrin receptor.
    Type: Grant
    Filed: June 12, 2009
    Date of Patent: May 29, 2012
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts, Ronghao Li
  • Antibodies that bind to EphA2 and methods of use thereof
    Patent number: 8183357
    Abstract: Provided herein is disclosure about the development and characterization of an antibody that binds to antigen EphA2 which is present on a variety of human cancers from breast, lung, prostate, and colons. Methods of diagnosing and treating various cancers by using such antibodies directed against this antigen are also disclosed.
    Type: Grant
    Filed: November 30, 2009
    Date of Patent: May 22, 2012
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts
  • Animal Model for Toxicology and Dose Prediction
    Publication number: 20120110682
    Abstract: The invention relates to the use of fetal tissues to generate a tissue model in a non-human animal. The tissue model comprises target tissues allowed to progress through development in vivo in a non-human host in order to obtain tissues having a mature phenotype that can be used to assess toxicity and/or efficacy of an agent.
    Type: Application
    Filed: January 11, 2012
    Publication date: May 3, 2012
    Applicant: MACROGENICS, INC.
    Inventors: Jennie P. Mather, Peter F. Young
  • LUCA2 and Antibodies That Bind Thereto
    Publication number: 20110045006
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, LUCA2. The invention also provides a family of monoclonal antibodies that bind to antigen LUCA2, methods of diagnosing and treating various human cancers and diseases that express LUCA2.
    Type: Application
    Filed: October 29, 2010
    Publication date: February 24, 2011
    Applicant: MacroGenics West, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts
  • LUCA2 and antibodies that bind thereto
    Patent number: 7847070
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, LUCA2. The invention also provides a family of monoclonal antibodies that bind to antigen LUCA2, methods of diagnosing and treating various human cancers and diseases that express LUCA2.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: December 7, 2010
    Assignee: Raven biotechnologies, inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts
  • Antibodies that bind to EphA2 and methods of use thereof
    Patent number: 7776328
    Abstract: Provided herein is disclosure about the development and characterization of an antibody that binds to antigen EphA2 which is present on a variety of human cancers from breast, lung, prostate, and colons. Methods of diagnosing and treating various cancers by using such antibodies directed against this antigen are also disclosed.
    Type: Grant
    Filed: June 30, 2009
    Date of Patent: August 17, 2010
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Penelope E. Roberts
  • TES7 AND ANTIBODIES THAT BIND THERETO
    Publication number: 20100183605
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, TES7. The invention also provides a family of monoclonal antibodies that bind to antigen TES7, methods of diagnosing and treating various human cancers and diseases with TES7.
    Type: Application
    Filed: March 16, 2010
    Publication date: July 22, 2010
    Applicant: MACROGENICS, INC.
    Inventors: Jennie P. Mather, Tony W. Liang
  • TRANSFERRIN RECEPTOR ANTIBODIES
    Publication number: 20100166745
    Abstract: The invention provides further characterization of the disease and cancer-associated antigen, transferrin receptor. The invention also provides a novel family of antibodies that bind to the transferrin receptor, methods of diagnosing and treating various human cancers and diseases that express transferrin receptor.
    Type: Application
    Filed: June 12, 2009
    Publication date: July 1, 2010
    Inventors: Jennie P. MATHER, Penelope E. Roberts, Ronghao Li
  • Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
    Patent number: 7744878
    Abstract: Provided herein is disclosure about the development and characterization of an antibody (mPA7) which binds to antigen CD46 which is present on a variety of human cancers from ovary, breast, lung, prostate, colon, kidney, and pancreas. Methods of diagnosing and treating various cancers by using antibodies such as mPA7 directed against this antigen are also disclosed.
    Type: Grant
    Filed: September 19, 2006
    Date of Patent: June 29, 2010
    Assignee: Raven biotechnologies, inc.
    Inventor: Jennie P. Mather
  • KID31 And Antibodies That Bind Thereto
    Publication number: 20100150921
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, KID31. The invention also provides modulators of KID31, including a family of monoclonal antibodies that bind to antigen KID31, and methods of diagnosing and treating various human cancers and diseases with KID31.
    Type: Application
    Filed: February 13, 2010
    Publication date: June 17, 2010
    Applicant: RAVEN BIOTECHNOLOGIES, INC.
    Inventors: Jennie P. Mather, Deryk T. Loo
  • TES7 and antibodies that bind thereto
    Patent number: 7718774
    Abstract: The invention provides the identification and characterization of disease and cancer-associated antigen, TES7. The invention also provides a family of monoclonal antibodies that bind to antigen TES7, methods of diagnosing and treating various human cancers and diseases that express TES7.
    Type: Grant
    Filed: November 8, 2007
    Date of Patent: May 18, 2010
    Assignee: MacroGenics, Inc.
    Inventors: Jennie P. Mather, Tony W. Liang
  • ADAM-9 Modulators
    Publication number: 20100111951
    Abstract: The invention provides the identification and characterization of a disease and cancer-associated antigen, KID24. The invention also provides modulators of KID24, including a family of monoclonal antibodies that bind to antigen KID24, and methods of diagnosing and treating various human cancers and diseases with KID24.
    Type: Application
    Filed: January 14, 2010
    Publication date: May 6, 2010
    Applicant: RAVEN BIOTECHNOLOGIES, INC.
    Inventors: Jennie P. Mather, Deryk T. Loo